Company Filing History:
Years Active: 2011
Title: The Innovations of Peter Guldner
Introduction
Peter Guldner is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. His work focuses on enhancing the delivery and effectiveness of active ingredients in medication.
Latest Patents
Peter Guldner holds a patent for an oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient. This innovative formulation allows for the production of oral pharmaceutical compositions containing propiverine in amounts ranging from 4 mg to 60 mg. The design includes a retarding coating or a matrix that prolongs the release of the active agent, improving patient outcomes.
Career Highlights
Guldner is associated with Apogepha Arzneimittel GmbH, where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the formulation of medications that require controlled release mechanisms.
Collaborations
Peter Guldner has collaborated with notable colleagues such as Thomas Gramatte and Peter Gruber. Their combined efforts contribute to the innovative projects at Apogepha Arzneimittel GmbH.
Conclusion
Peter Guldner's contributions to pharmaceutical innovations, particularly in oral dosage forms, highlight his role as a key inventor in the industry. His patent work continues to influence the development of effective medication delivery systems.